Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01105663 · ClinicalTrials.gov registry record
Pharmacologic Impact on Sedation Assessments
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 175
- Enrollment target
NCT01105663: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT01105663 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01105663 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
PISA is an ancillary study to the NIH funded clinical RESTORE Trial (U01 HL086622). This study will provide data that may allow for improved dosing recommendations in this critically ill population of children.
Primary Outcome
This is a pharmacokinetic, pharmacogenetic and pharmacodynamic study examining heritable (specific polymorphisms) on drug exposure, metabolite formation and pharmacodynamic response.
Interventions
- OTHER Pharmacokinetic Sampling and pharmacogenetic analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-12 |
What the finished NCT01105663 record still lists
NCT01105663 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pharmacokinetic Sampling and pharmacogenetic analysis is the first listed.
NCT01105663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01105663 about?
NCT01105663 is a clinical study titled "Pharmacologic Impact on Sedation Assessments". PISA is an ancillary study to the NIH funded clinical RESTORE Trial (U01 HL086622). This study will provide data that may allow for improved dosing recommendations in this critically ill population of children.
What is the current status of trial NCT01105663?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2010-03. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01105663?
The interventions under investigation include: Pharmacokinetic Sampling and pharmacogenetic analysis (OTHER).
Who is sponsoring clinical trial NCT01105663?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia